Saturday , January 16 2021

FDNA publishes a study in the New Artificial Intelligence Standard Defined Nature Medicine in Healthcare



Boston – (Business Wire) – FDNA,
A leader in artificial intelligence and precision medicine
Collaborating with a team of influential scientists and researchers
Published a landmark study on the use of facial analysis in search
Genetic disorders. The findings of this paper suggest that this kind of
Technology adds significant value to personal care and it will become
Standard between deep learning-based genetic tools.

Paper, title "Recognize
Facial Feinotypes of Genetic Disorders using Deep Learning
", Was
Peer-Reviewed Journal Nature Medicine (January 07,
2019) as a research product for three years. Deep study
Technical Discussion, DeepGustralTM, A novel is facial
An analysis structure that publishes hundreds of facial phenotypes
Diseases and Genetic Variations

"This is a long-awaited success in medical genetic science
Ultimately the fusion comes, "said Dr. Karen Grip, CMO
FDNA and paper co-authors. "With this study, we have shown it
Like DeepJustalt, adding automated face analysis structure
Clinical workflows can help in getting previous diagnosis and treatment,
And promise better quality of life. "

Yarron Gurovich, FDNA CTO and the first author of the paper, added, "The
Certainly the ability to describe the phenotype increases
The gate of future research and applications, and new identities
Genetic Syndrome It shows how the state can be successfully implemented
Art algorithms, such as deep teaching, for a challenging field
Where available information is available, it is unbalanced
Every conditioned patients, and where a large amount of support is needed
Terms are great. "

This technology replaces phenotyping of the next generation (NPP)
Capture, structure and analysis of complex human physics
Information-and more than 150,000 patients are trained on dataset
By Face 2 Jean,
Community-based Feniting Platform For the purposes of this study,
17,000 patient images representing more than 200 syndrome were used.

Findings from the study include:

  • Deep Gastalt correctly identified 91% gaining top-10 accuracy
    Syndrome on 502 images;

  • Three additional experiments in impartial expert clinics;

  • In medical genetics, adds significant value to phenotypic evaluation,
    Genetic testing, research and correctness medicine;

  • Used to coincide with next generation sequencing (NGS)
    Best result

"Artificial Intelligence is a lifestyle of personal care
On its way to becoming a standard protocol for genom progressively
FCNA CEO Derek Galbman says. "Over the years, we've done
Completely relying on medical professionals to identify
Genetically Associated Disease Ultimately we have reached this reality
The work can be enhanced by AI, and we are on track to stay on track
Leading AI Framework using medical notes, medical images, and videos
And voice recordings for years to enhance touring
Come on. "

To learn more about the effect of genomics and this study
Personalized medicine, Register
Here for our webinar
.

About FDNA
FDNA develops AI techniques and size platforms
Thousands of globally used by clinical, research, and lab sites
Clinical Genomics Space Advanced Deep Study, Using FDNA
Front generation Fenotyping (NGP) technology capture, structure, and
Analyze complex human physical data to produce functional genetics
Intuition Since its inception in 2011, FDNA has retained its position
Leading AII, genomics, and precision medicine. For more information,
Visit www.FDNA.com.


Source link